Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Partners
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed Announces Proposed Public Offering of Common Shares

April 12, 2022

Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting

April 10, 2022

Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors

April 8, 2022

Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress

March 31, 2022

Affimed to Report Full Year 2021 Financial Results & Corporate Update on March 31, 2022

March 24, 2022

Affimed Announces Clinical Updates at the Annual Meeting of the American Association for Cancer Research

March 8, 2022

Affimed Announces Publication of Preclinical Data Demonstrating Cytotoxic Potency and Efficacy of NK Cells Precomplexed with Innate Cell Engagers after Freezing & Thawing

February 9, 2022

Affimed to Present at Upcoming Investor Events

February 8, 2022

Affimed Announces Completion of Enrollment in REDIRECT, the Registration-Directed Study of AFM13 in PTCL, and Provides Business Update

January 6, 2022

Affimed to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 5, 2022

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25

Events

All
Scientific
Investors

03Jun

ASCO Annual Meeting

June 3 - 7, 2022 (Chicago, US)

WebcastsMore events

Affimed GmbH
Technologiepark
Im Neuenheimer Feld 582
69120 Heidelberg, Germany

Phone: +49 (0)6221-6743-60
Fax: +49 (0)6221 6743-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Partners
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance
    • Press Release Distribution
  • Careers
    • Culture

© 2022 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact